Displaying companies
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven history of progressing cell-depleting treatments through clinical trials, and a strong pipeline. | San Francisco | CA | 20 - 50 | 2025 | $120,000,000 |
Tenvie Therapeutics is a biotechnology company founded to improve patients' lives with neurological, cardiometabolic, and ophthalmic diseases. The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lysosomal issues, with a robust pipeline inherited from Denali Therapeutics. Tenvie is progressing a range of therapeutics aimed at addressing neurological, cardiometabolic, and ophthalmic conditions. Its collection of fully owned, highly brain-penetrant, and precisely designed peripherally restricted small molecules targets three main factors of disease: alleviating inflammation, correcting metabolic dysfunction, and rejuvenating lysosomal function. | San Francisco | CA | 20 - 50 | 2025 | $200,000,000 |
Helicore Biopharma is at the forefront of developing cutting-edge treatments for obesity and related disorders. | 5 - 10 | 2025 | $65,000,000 | ||
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases. | San Diego | CA | 20 - 50 | 2024 | $480,000,000 |
Arini is an AI receptionist for dental practices that answers phone calls, and schedules appointments. | San Francisco | CA | 1 - 10 | 2024 | $500,000 |
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases. | Knoxville | TN | 2 - 10 | 2024 | $3,000,000 |
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area. | San Francisco | CA | 50 - 200 | 2024 | $1,000,000,000 |
Jupiter Endovascular is a medical technology start-up. Its mission is to cover the entire spectrum of cardiovascular illness, seeing compelling potential to reinvent treatments for millions of people. | Menlo Park | CA | 10 - 50 | 2024 | $21,000,000 |
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | Boulder | CO | 20 - 50 | 2024 | $41,000,000 |
Praia Health is a cutting-edge consumer platform for health systems that transforms the delivery of personalised health solutions on a large scale, allowing digital transformation. | Chicago | IL | 20 - 50 | 2024 | $20,000,000 |
Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation. That aims to focus on pausing and restarting biological functions through freezing to prevent tissue damage in dead bodies. | San Francisco | CA | 20 - 50 | 2024 | $48,000,000 |
Z-Score Health is a forward-thinking healthcare company leveraging technology to offer personalized preventive care. Their approach integrates comprehensive health risk assessments using a sophisticated SaaS platform and mobile applications, focusing on areas like women's health, geriatric care, and sexual health. They emphasize patient satisfaction and convenience, aiming to make healthcare more accessible and effective through technology. This summary provides an essence of their services and mission; for a detailed description, you would need to refer to their official website or professional profile. | Atlanta | GA | 1 - 10 | 2024 | $600,000 |
Kabilah streamlines shift change for nurses with an AI-powered assistant that replaces paper reports. | Stanford | CA | 1 - 10 | 2024 | $500,000 |
With a mission to keep athletes active and thriving in their chosen sports for as long as possible, Eternal provides members with a holistic understanding of their health, fitness, and benchmarks for key markers of the aging process along with guidance from high-performance care teams to support every stage of an athlete’s journey. | 10 - 50 | 2024 | $13,000,000 | ||
Oma Care is to empower, assist, and compensate people who care for our most vulnerable citizens—family caregivers. | San Francisco | CA | 2 - 10 | 2024 | $500,000 |
AT4K specializes in and alone performs in-person autism evaluations. It is committed to reducing the time it takes for children to be evaluated for Autism Spectrum Disorder (ASD) and providing comprehensive and reliable evaluations that enable early intervention and individualized care. | Grapevine | TX | 10 - 50 | 2024 | $2,500,000 |
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications. | Waltham | MA | 4 | 2024 | $602,600,000 |
Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free for commercial applications. By enabling accurate predictions without the need for multiple sequence alignments, Chai-1 advances the capabilities of molecular modeling in the life sciences. | San Francisco | CA | 5 - 20 | 2024 | $101,000,000 |
Astrix builds AI purchasing agents for healthcare providers. Astrix helps providers secure better deals on recurring medical supplies, equipment, and pharmacy orders by using AI to find the best offers from reputable vendors. Powered by generative AI, Astrix aggregates and normalizes data from millions of sources, delivering actionable pricing insights for buyers and sellers alike. Our team brings expertise in building AI systems from Palantir, Oxford, Duke Health, and MedStar Health. Backed by Y Combinator, Astrix operates globally from San Francisco, NYC, and London. | 2 - 10 | 2024 | $2,000,000 | ||
Thrive AI Health builds an AI health coach. Thrive AI Health use generative AI to hyper-personalize and scale behavior change. | 10 - 50 | 2024 | $8,049,999 | ||
K-Scale Labs is a robotic engineering company specializing in creating open-source humanoid robots. | New York | NY | 2 - 10 | 2024 | $500,000 |
World Class Health is a Hospitals and Health Care company. | New York | NY | 1 - 10 | 2024 | |
Noded Ai is preparing yourself for that customer meeting is tough. Noded brings them all together using your notes history and gives you exactly what you needed , when you need it. So you’re always prepared and one step ahead. | New York | NY | 10 - 50 | 2024 | $48,000,000 |
Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. The Company is advancing a pipeline of therapeutic candidates addressing areas of high unmet need including wet age-related macular degeneration (AMD). Eyconis is partnered with a syndicate of leading biopharma investors including Frazier Life Sciences, RA Capital Management, venBio Partners, and HealthQuest Capital. The Company is headquartered in Redwood City, California, including research & development laboratories with scientific and manufacturing team members. | 10 - 50 | 2024 | $85,251,248 | ||
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines. | 10 - 50 | 2024 | $93,500,000 | ||
Our HIPAA-Compliant AI Assistant will save you hours of paperwork time a week. Summarize parent interviews, caregiver trainings, and RBT supervision. Automate insight extraction from client records. Generate huge parts of treatment plans.
Interested in trying it out? No credit card required. No client data needed. Sign up for free! | 1 - 10 | 2024 | |||
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi. | Boston | MA | 10 - 50 | 2024 | $100,000,000 |
DeltaGen is an enterprise AI company transforming buyside M&A by automating 80% of manual workflows—eliminating inefficiencies and accelerating deal velocity for corporate development teams, private equity firms, and strategic acquirers. Unlike traditional AI tools that rely on manual prompting, DeltaGen’s no-prompt AI delivers highly accurate, deterministic insights with seamless integration. | 50 - 268 | 2024 | $2,700,000 | ||
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients with neurodegenerative illnesses. | South San Francisco | CA | 10 - 50 | 2024 | $101,000,000 |
Seaport Therapeutics operates as a clinical stage biopharmaceutical company. | Boston | MA | 20 - 100 | 2024 | $325,000,000 |
Trovo Health uses AI technology to provide comprehensive healthcare solutions, combining smart algorithms with professional human coaching to deliver personalized patient care. | New York | NY | 10 - 50 | 2024 | $15,000,000 |
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on promising targets, and implementing them in disease areas with considerable unmet needs. | San Diego | CA | 10 - 50 | 2024 | $180,000,000 |
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases. | Waltham | MA | 50 - 200 | 2024 | $1,000,000,000 |
GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation. | 20 - 100 | 2024 | $300,000,000 | ||
careCycle is an AI workforce for Medicare agencies and FMOs, supporting top agencies in their operations. | 5 - 10 | 2024 | $2,000,000 | ||
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies. | 10 - 50 | 2024 | $105,000,000 | ||
GEMMABio is a therapeutics company that supports the rare disease community. | Philadelphia | PA | 50 - 100 | 2024 | $34,000,000 |
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages. | Wilmington | DE | 20 - 50 | 2024 | $5,500,000 |
Coeptis Therapeutics focuses on the development and acquisition of pharmaceutical products. Coeptis’ pipeline is evolving from the partnerships being created with multiple pharmaceutical companies currently. As these relationships unfold, the product pipeline will be updated accordingly. | Wexford | PA | 5 | 2024 | $25,192,500 |
Zarminali Health is a medical organization. | Chicago | IL | 20 - 50 | 2024 | $40,000,000 |
nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques. | Boston | MA | 50 - 100 | 2024 | $75,000,000 |
Nura Health is a molecular diagnostics company whose mission is to advance women's health through the development and delivery of novel practice-changing non-invasive tests. We prioritize innovative, evidence-based diagnostic methods enhanced by AI & Machine Learning in order to improve clinical outcomes for complex and debilitating diseases such as endometriosis, infertility disorders, and genetic conditions that impact quality of life and longevity. | 1 - 10 | 2024 | |||
Developing innovative therapeutics to materially improve the lives of patients. We strive to be transparent and open in our goals, plans, and progress. | San Diego | CA | 20 - 50 | 2024 | $370,000,000 |
KALM Therapeutics provides non-steroidical treatment for eczema and psoriasis. | Huntsville | AL | 2 - 10 | 2024 | $590,380 |
Endo Health creates a gamified ''AI endocrinologist'' for type 2 diabetes management. They are creating a pleasant AI medical assistant that will walk patients through every stage of diabetic control, complete with gamified involvement. | San Francisco | CA | 1 - 10 | 2024 | $1,000,000 |
Navigator Medicines operate as a biotech company that leads the advancement of biologics for targeted immune regulation & restoration. | Scotch Plains | NJ | 5 - 20 | 2024 | $100,000,000 |
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets. | San Francisco | CA | 5 - 20 | 2024 | $92,000,000 |
Advancing healthcare through adaptable and innovative inventory management solutions. | Haddonfield | NJ | 1 - 10 | 2024 | $1,250,000 |
SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services. | Somerville | MA | 1 - 10 | 2023 | $500,000 |
We believe that in order to improve healthcare outcomes for everyone, we need to align ourselves directly with patients and to help them at every clinical touchpoint. To do this, we are building MDandMe, with the goal of giving every person a doctor best friend they wish they had. | Carlsbad | CA | 5 - 10 | 2023 | $2,500,000 |
Georgetown Surgery Center is a healthcare service providing company that specializes in surgical services. | Georgetown | TX | 10 - 50 | 2023 | $1,816,032 |
Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to-severe asthma that only requires dosing every 6 months. Aiolos Bio was founded by an accomplished team with decades of drug development experience and leadership in the biotech industry. | San Francisco | CA | 20 - 50 | 2023 | $245,000,000 |
Prosper Health provides affordable and accessible therapy to autistic adults. Our therapy is neurodivergent affirming, covered by commercial insurance, and available via telehealth in multiple states. We are a startup on a mission to help autistic adults live happier and healthier lives. | 20 - 100 | 2023 | $16,234,237 | ||
Peregrine Health is a healthcare company formed by Integrative Life Network (ILN) and Integrative Health Centers. | Nashville | TN | 20 - 50 | 2023 | $13,514,671 |
Conduce Health is an unprecedented healthcare technology company constructed to be a holistic solution for multi-specialty value-based care. | New York | NY | 10 - 50 | 2023 | $3,000,000 |
Aligned Marketplace operates as a personalized primary care for workforce. | New York | NY | 10 - 20 | 2023 | $11,000,000 |
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies . | Los Angeles | CA | 5 - 20 | 2023 | $30,000,000 |
Caire is a developer of a virtual-first care platform that puts the patient at the center. | New York | NY | 10 - 50 | 2023 | $23,100,000 |
Being Health is a psychiatrist-led mental health practice that leverages the best of psychiatry. | New York | NY | 10 - 50 | 2023 | $5,400,000 |
Aera is a DAO investment management protocol that offers crowdsourced portfolio management advice to consumers. | Mountain View | CA | 1 - 10 | 2023 | $8,000,000 |
Selera Medical is developing a device-based treatment for heart failure, to treat fluid overload in heart failure patients with a one-time, minimally invasive procedure | Mountain View | CA | 2 - 10 | 2023 | $500,000 |
Atommap is a physics-based and ML-augmented computational drug discovery platform | New York | NY | 5 - 10 | 2023 | $7,084,989 |
Optain is a manufacturer of medical equipment and software. Optain is to make healthcare available to all people so that all can live healthy lives. Optain uses AI to create affordable clinical assistance solutions that make illness screening simple, anytime, and anywhere. | New York | NY | 10 - 50 | 2023 | $38,000,000 |
GenHealth.ai provides healthcare solutions using generative AI trained on encoded medical events. Its product is a generative healthcare AI publicly available. It includes a foundation transformer model (new neural networks with excellent memory), an API, and user applications that can generate and predict future sequences of health events using historical events. Together they can be used to build a large variety of customized applications. | Vienna | VA | 1 - 20 | 2023 | $12,999,995 |
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors. | Palo Alto | CA | 5 - 10 | 2023 | $6,500,000 |
Nicer Inc provides training and development services. The Company offers automobile driving schools. | 5 - 10 | 2023 | $2,000,000 | ||
Century Health accelerates drug development and commercialization by applying AI to real-world data. It is far too slow today to answer critical questions because the richest clinical data is locked away in silos. Our platform does the heavy lifting to rapidly get you the insight you need, all while supporting the research community and protecting patient privacy. | Miami | FL | 10 - 50 | 2023 | $2,000,000 |
About HAPPY POTATO - Perfect Fries ! The world's best Flavored French Fries ! Feel the Flavor with everyone's favorite French fries Products Flavoring Perfect Fries | 10 - 100 | 2023 | $7,693,035 | ||
Avenue Biosciences is pioneering the future of biotechnology, with a mission to transform the development of protein biologics for healthcare advancements. Our cutting-edge, high-throughput engineering platform transforms the production of protein biologics by enabling the simultaneous optimization of critical elements. This breakthrough technology enhances production efficiency, accelerates development timelines, and tackles the challenges of producing complex proteins.
Our goal is to drive significant progress in the pharmaceutical industry by providing turnkey solutions that streamline production, improve quality, and unlock new therapeutic possibilities. Backed by validated proof of concept and compelling data, Avenue Biosciences is on a journey to transform healthcare and push the boundaries of what’s possible in protein biologics.
We're a team of brilliant minds, each an expert in their field, united by a shared mission to make a real impact in a novel area of biotechnology. We are a highly experienced, entrepreneurial minded team with an impressive scientific background, that lives and breathes a casual, committed, and positive culture and spirit.
A closer look
We revolutionize protein production with our groundbreaking high-throughput engineering platform. This innovative technology significantly enhances overall production efficiency and quality. We optimize the production of natural single-chain proteins, monoclonal antibodies, bispecific antibodies, fusion proteins, mRNA therapies, and vaccines. Additionally, our platform accelerates the drug and vaccine discovery process.
Our mission is to accelerate the development of protein expression systems, covering new protein therapeutics, biosimilars, and other protein expression systems within the biotechnology industry. Our engineering platform empowers biotechnology and pharmaceutical industry customers to speed up development timelines and facilitate the production of difficult-to-express proteins. | Palo Alto | CA | 10 - 50 | 2023 | $2,500,000 |
UnityAI uses AI to enhance the management of hospital beds, optimize resource allocation, and elevate the quality of patient care. | Nashville | TN | 5 - 20 | 2023 | $4,000,000 |
Coral Care is a venture-backed company on a mission to help parents access the care they need to help their children thrive. | New York | NY | 20 - 50 | 2023 | $6,500,000 |
Medication errors cost the healthcare industry $40 billion each year, the largest contributor being the manual processes employed by pharmacies. Wattson Health's automation platform integrates with pharmacies' existing systems and enables them to fill prescriptions error-free in a matter of seconds vs. hours or even days. | San Francisco | CA | 2 - 10 | 2023 | $500,000 |
A forward-thinking company committed to responsibly integrating new technologies in the healthcare industry. | Southlake | TX | 10 - 50 | 2023 | $2,879,586 |
Mascotte handles your client communications & admin tasks in a way that’s tailored to your practice. You get to track everything in real-time and enjoy comprehensive oversight as our dedicated teams handle the operational workload. | Miami | FL | 10 - 50 | 2023 | $1,200,000 |
Counsel Health helps patients to get access to medical advice virtually. | Canton | MA | 20 - 50 | 2023 | $36,000,000 |
Mozarc Medical leverages both companies’ leadership and expertise to develop transformative kidney health technologies. The company focuses on the development of innovative technologies that reshape kidney health with patient-centered solutions. | Minneapolis | MN | 1,000 - 5,000 | 2023 | $22,399,376 |
Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites | Cambridge | MA | 50 - 100 | 2023 | $30,877,444 |
Axena Health is a women-led company dedicated to improving the lives of women with pelvic floor disorders by leveraging the power of digital technology. | Auburndale | MA | 20 - 50 | 2023 | $36,200,000 |
Granza Bio is a company that developing cancer therapies based on human body's immune system. | San Francisco | CA | 2 - 10 | 2023 | $7,640,000 |
Shasta Health is a physical therapy center that offers patient acquisition, billing, care plans, and other care facilities. | San Francisco | CA | 2 - 10 | 2023 | $500,000 |
Andromeda Surgical is a developer of autonomous robots intended to make surgery more consistent, error-free, and efficient. | San Francisco | CA | 5 - 20 | 2023 | |
Savoy Life is a virtual care solution that connects long-term care operators and residents with high-quality, coordinated healthcare services. | Virginia | NE | 2 - 10 | 2023 | $3,000,000 |
Biostate AI develops generative AI that benefit all human health. | Palo Alto | CA | 20 - 50 | 2023 | $16,000,000 |
Kardigan is a patient-driven heart health firm that is revolutionizing cardiovascular drug development to produce medicines that take patients from symptom management to functional cures. | South San Francisco | CA | 10 - 200 | 2023 | $554,000,000 |
twenty30 health brings a technology-enabled, patient-first and coordinated, multimodal approach to delivery of obesity care. We deliver whole-person, evidence-based interventions, with a best-in-class provider network to drive sustained weight loss and metabolic health. | Philadelphia | PA | 10 - 50 | 2023 | $5,190,000 |
Silo Pharma, Inc. is a developmental stage biopharmaceutical company. The Company specializes in developing novel therapeutics that address underserved conditions including PTSD, stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. Silo Pharma operates in the United States. | Sarasota | FL | 3 | 2023 | $12,006,060 |
Synaptrix is committed to offering free of drugs, lasting alternatives for postoperative pain treatment using NOVABLOC. | Alpharetta | GA | 2 - 10 | 2023 | $10,000,000 |
Fortuna streamlines Medicaid navigation for consumers, covering eligibility, enrollment, and renewal processes seamlessly. | New York | NY | 5 - 20 | 2023 | $22,000,000 |
Frontera Health is changing autism care in underprivileged regions with AI-powered tools that assist physicians in evaluating and treating children with autism and related diseases. | 2 - 10 | 2023 | $500,000 | ||
Anaphero is health care unit that helps in reducing clinical staff shortage using virtual agents that can safely interact with patients. | 2 - 10 | 2023 | |||
Felix&Fido combines technology with operational excellence in a human-centered workplace to provide you with the best pet care possible. With multi-modal options, you never have to compromise on your pet's care. | Seattle | WA | 10 - 50 | 2023 | $4,000,000 |
ParcelBio is a company that creating a programmable method for safely and precisely delivering mRNA to many cell types in the body. | San Francisco | CA | 5 - 10 | 2023 | $500,000 |
ROSE Diagnostics' objective is to improve cancer diagnostics by moving the pathology lab to the cancer biopsy clinic and offering a suite of simple point-of-care diagnostic devices. | Carlsbad | CA | 1 - 10 | 2023 | $1,005,000 |
Retension Pharmaceuticals is developing RTN-001, a differentiated, tissue-targeted PDE5 inhibitor that has been optimized for the treatment of uncontrolled hypertension. RTN-001 has been evaluated in over 265 subjects across 9 clinical trials. In these studies, RTN-001 was well tolerated and demonstrated a sustained and clinically significant impact on central and brachial blood pressure in patients with uncontrolled hypertension. RTN-001 is a second generation PDE5i that preferentially distributes to cardiovascular tissues, where it acts to mediate a sustained and clinically significant impact on central and brachial blood pressure in patients with uncontrolled hypertension. | Falls Church | VA | 2 - 10 | 2023 | $25,400,000 |
Edgewood Oncology is a clinical-stage biotechnology business established to fulfill the potential of BTX-A51 for patients with solid tumors that are genetically specified and hematologic malignancies. Our goal is to create a novel treatment that will prolong and enhance the lives of those with the greatest unmet medical needs. | Brookline | MA | 2 - 10 | 2023 | $20,000,000 |
Personalized weight loss backed by science. Eden's elite team of board-certified doctors and pharmacists specializes in weight loss and metabolic health, offering proven prescriptions and continuous support for tangible outcomes. | 10 - 20 | 2023 | |||
Decoda Health (YC S23) transforms healthcare administration with AI-driven medical assistants, empowering staff to shift their focus from tedious tasks to what truly matters — providing exceptional patient care. | San Francisco | CA | 2 - 10 | 2023 | $500,000 |
Flair Health extends medical care virtually, offers personalized nutrition and health coaching for patients with chronic conditions. | San Francisco | CA | 2 - 10 | 2023 | $500,000 |
The Catch Mobile Health team brings together accomplished business and medical professionals from across the country with the shared vision to improve access to specialist care in rural and underserved communities. | 5 - 20 | 2023 | $2,275,000 | ||
Health Harbor is a healthcare data platform designed to automate billing healthcare practices and RCM. | San Francisco | CA | 1 - 10 | 2023 |
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.